Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic Insomnia

Summary

The purpose of this study is to assess whether ramelteon, once daily (QD), can facilitate the discontinuation of zolpidem in subjects with chronic insomnia.

Timeline

Start

2007-04

Primary completion

2008-03

Completion

2008-05

Outcome

Missed primary endpoint

registry Ramelteon 8 mg QD vs Placebo QD; p = 0.484; Adjusted Odds Ratio 0.71 (95% CI 0.27 to 1.85) NCT00492232 ↗

Drugs

Indications